318.00
-4.50
(-1.40%)
At close: January 10 at 5:36:26 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Habib Ramdani | Interim CEO & CFO | 344.22k | -- | 1976 |
Mr. Marc Bistuer | Deputy CEO and Head of Compliance & Corporate Quality Assurance | 328.54k | -- | 1962 |
Ms. Sandrine Brunel | Head of Corporate Communications | -- | -- | -- |
Ms. Nathalie Pollet | Head of Global Marketing & Market Development | -- | -- | -- |
Ms. Francesca Cortella | Head of Corporate Human Resources | -- | -- | -- |
Ms. Sophie Favini | Head of Global Business Operations | -- | -- | -- |
Mr. Bertrand Havrileck | Head of Corporate R&D | -- | -- | -- |
Mr. André Mathieu | Head of Global Industrial Operations, Supply Chain and Sourcing | -- | -- | -- |
Manuela Rodríguez | Director of Financial Projects | -- | -- | -- |
Virbac SA
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
- Full Time Employees:
- 5,459
Description
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Corporate Governance
Virbac SA’s ISS Governance QualityScore as of January 1, 2025 is 8. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 9; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 17, 2025 at 3:00 PM UTC - March 21, 2025 at 3:00 PM UTC
Virbac SA Earnings Date
Recent Events
June 25, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
0QOK.IL Roche Holding AG
269.50
-1.10%
RHO6.SG Roche Holding AG
35.41
+0.69%
RHO6.BE Roche Holding AG
35.60
0.00%
AZNCF AstraZeneca PLC
135.50
0.00%
COPN.SW Cosmo Pharmaceuticals N.V.
64.20
-0.77%
RHHVF Roche Holding AG
288.71
-0.44%
ORNBV.HE Orion Oyj
45.13
+0.42%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
53.35
-1.20%
RO.SW Roche Holding AG
287.00
-1.37%
GRF.MC Grifols, S.A.
9.06
-0.57%